Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Amivas Bests La Jolla In Race For US Approval Of Antimalarial Artesunate
May 30 2020
•
By
Sue Sutter
US FDA approval of Amivas’ artesunate has thrown a wrench in La Jolla’s plans to come to market with the same drug • Source: Shutterstock
More from New Products
More from Scrip